Controversies in Lung Cancer: Heterogeneity in Treatment Recommendations for Stage III NSCLC According to Disease Burden and Oncogenic Driver Alterations-Reference-Cited by-同舟云学术

Controversies in Lung Cancer: Heterogeneity in Treatment Recommendations for Stage III NSCLC According to Disease Burden and Oncogenic Driver Alterations

Published:2022-06 Issue:4 Volume:23 Page:333-344
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Harris Jeremy P,Fujimoto Dylann K,Nagasaka Misako^ORCID,Ku Eric,Harada Garrett^ORCID,Keshava Hari,Mahtabifard Ali,Longoria Javier,Patel Niral^ORCID,Seyedin Steven,Simon Aaron^ORCID,Chen Allen^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference43 articles.

1. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial p;Bradley;Lancet Oncol,2015

2. Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 randomized clinical trial;Chun;J Clin Oncol Off J Am Soc Clin Oncol,2017

3. PROCLAIM: randomized phase III trial of pemetrexed-cisplatin or etoposide-cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small-cell lung cancer;Senan;J Clin Oncol,2016

4. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer;van Meerbeeck;J Natl Cancer Inst,2007

5. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol Off J Am Soc Clin Oncol,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of radiotherapy versus surgical resection following neoadjuvant chemoimmunotherapy in potentially resectable stage III non-small-cell lung cancer: A propensity score matching analysis;Lung Cancer;2024-08

2. FAM189A2 plays a tumour suppressor role in lung adenocarcinoma by influencing cell apoptosis, CXCR4 expression and tight junction proteins;Tissue and Cell;2024-08

3. Preoperative CT-based radiomic prognostic index to predict the benefit of postoperative radiotherapy in patients with non-small cell lung cancer: a multicenter study;Cancer Imaging;2024-05-13

4. Preoperative CT-Based Radiomic Prognostic Index to Predict the Benefit of Postoperative Radiotherapy in Patients with Non-Small Cell Lung Cancer: A Multicenter Study;2024-03-20